MAPK3 and prostate cancer: The results showed that ATP- and BzATP-driven migration and invasion of prostate cancer cells were significantly suppressed when PI3K/AKT or ERK1/2 signaling pathway was inhibited (Fig. 4C–D and S6C–D Figure).